Formulation of wax oxybenzone microparticles using a factorial approach

Journal of Microencapsulation

Volumn 27, Issue 7, 2010, Pages 628-639

  Gomaa, Y A ^a   Darwish, I A ^a   Boraei, N A ^a   El Khordagui, L K ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Carnauba wax; Factorial design; Oxybenzone; Sunscreen

Indexed keywords

CARNAUBA WAX; OXYBENZONE; SUNSCREEN; UNCLASSIFIED DRUG; WAX;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; FACTORIAL ANALYSIS; HYDROPHILICITY; LIPOPHILICITY;

BENZOPHENONES; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SUNSCREENING AGENTS; WAXES;

EID: 77957812540     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.506580     Document Type: Article

References (46)

1. Albertini B, Mezzena M, Passerini N, Rodriguez L, Scalia S. Evaluation of spray congealing as technique for the preparation ofhighly loaded solid lipid microparticles containing the sunscreen agent, avobenzone. J Pharm Sci, 2009;98:2759-69.
2. Bhavsar MD, Tiwari SB, Amiji MM. Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using facto-rial design. J Control Release, 2006;110:422-30.
3. Denet AR, Vanbever R, Préat V. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev, 2004;56:659-74.
4. Dorgan PD. Waxes in cosmetics. Drug Cosmet Ind, 2002;133:30-3.
5. Felton LA, Wiley CJ, Godwin DA. Influence of hydroxypropyl- betacyclodextrin on the transdermal permeation and skin accumulation of oxybenzone. Drug Dev Ind Pharm, 2002;28:1117-24.
6. Felton LA, Wiley CJ, Godwin DA. Influence of cyclodextrin complexation on the in vivo photoprotection effects of oxybenzone. Drug Dev Ind Pharm, 2004;30:95-102.
7. Furniss BS, Hannaford AJ, Smith PWG, Tatchell AR, 1989. Specroscopic methods and the interpretation of spectra. Vogel's textbook of practical organic chemistry. England: Longman Group UK LTD. pp. 254-316.
8. Gogna D, Jain SK, Yadav AK, Agrawal GP. Microsphere based improved sunscreenformulation of ethylhexyl methoxycinnamate. Curr Drug Deliv, 2007;14:153-9.
9. Gomaa YA, El-Khordagui LK, Boraei NA, Darwish IA. Chitosan microparticles incorporating a hydrophilic sunscreen agent. Carbohydr Polym, 2010;81:234-42.
10. González H, Farbrot A, Larkö O, Wennberg AM. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol, 2006;154:337-40.
11. González S, Fernández-Lorente M, Gilaberte-Calzada Y. The latest on skin photoprotection. Clin Dermatol, 2008;26:614-26.
12. Gulbake A, Jain A, Khare P, Sanjay KJ. Solid lipid nanoparticles bearing oxybenzone: In vitro and in vivo evaluation. J Microencapsul, 2010;27:226-33.
13. Guyot M, Fawaz F. Nifedipine loaded-polymeric microspheres: Preparation and physical characteristics. Int J Pharm, 1998;17:61-74.
14. IannuccelliV, Sala N, Tursilli R, Coppi G, Scalia S. Influence oflipospheres preparation on butyl-methoxydibenzoylmethane photostability. Eur J Pharm Biopharm, 2006;63:140-45.
15. Jain SK, Jain NK. Multiparticulate carriers for sun-screening agents. Int J Cosmet Sci, 2010;32:89-98.
16. Janjua NR, Mogensen B, Andersson AM, Petersen JH, Henriksen M, Skakkebaek NE, Wulf HC. Systemic absorption of the sunscreens benzophenone-3, octylmethoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol, 2004;123:57-61.
17. Jaspart S, Bertholet P, Piel G, Dogne JM, Delattre L, Evrard B. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm, 2007;65:47-56.
18. Jaspart S, Piel G, Delattre L, Evrard B. Solid lipid microparticles: formulation, preparation, characterization, drug release and applications. Expert Opin Drug Deliv, 2005;2:75-87.
19. Jenning V, Gohla S. Comparison of wax and glyceride solid lipid nanoparticles (SLN®). Int J Pharm, 2000;196:219-22.
20. Labouta HI, El-Khordagui LK, Molokhia AM, Ghaly GM. Multivariate modeling of encapsulation and release of an ionisable drug from polymer microspheres. J Pharm Sci, 2009;89:4603-15.
21. Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release, 2003;90:313-22.
22. Larsson K. Classification of glycerides crystal forms. Acta Chem Scand, 1996;20:2255-60.
23. Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T. Effects of process and formulation parameters on characteristics and internal morphology of poly (D,L-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm, 2008;68:214-23.
24. Martinez-Sancho C, Herrero-Vanrell R, Negro S. Optimization of aciclovir poly (D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. Int J Pharm, 2004;273:45-56.
25. Montgomery DC, 1997. Experiments with a single factor: The analysis of variance. Design and analysis of experiments. New York: John Wiley & Sons. pp. 63-117.
26. Ohba N. Hydrophile-lipophile balance values for O/W emulsions stabilized by nonionic surfactants. II. Required HLB hydrophile-lipophile balance values of the oil mixture. Bull Chem Soc Jpn, 1962;35:1021-5.
27. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 2009;366:170-84.
28. Pasquali RC, Taurozzi MP, Bregni C. Some considerations about the hydrophilic-lipophilic balance system. Int J Pharm, 2008;356:44-51.
29. Passerini N, Perissuti B, Moneghini M, Voinovich D, Albertini B, Cavallari C, Rodriguez L. Characterization of carbamazepine-Gelucire 50/13 microparticles prepared by a spray congealing process using ultrasounds. J Pharm Sci, 2002;91:699-707.
30. Patel M, Jain SK, Yadav AK, Gogna D, Agrawal GP. Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy. Drug Deliv, 2006;13: 323-30.
31. Roberts M, Cespi M, Ford JL, Dyas AM, Downing J, Martini LG, Crowley PJ. Influence of ethanol on aspirin release from hypremellose matrices. Int J Pharm, 2007;332:31-7.
32. Roth W, Setnik B, Zietsch M, Burst A, Breitenbach J, Sellers E, Bernnan D. Ethanol effects on drug release from verapamil meltrex, an innovative melt extruded formulation. Int J Pharm, 2009;368:72-5.
33. Schauder S, Ippen H. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Derm, 1997;37:221-32.
34. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol, 2006; 19:296-302.
35. Schwartz JB, Simonelli AP, Higuchi WI. Drug release from wax matrices. II. Application of a mixture theory to the sulfanilamide-wax system. J Pharm Sci, 1968;57:280-2.
36. Shah V, Elkins J, Skelly J. Relationship between in vivo skin blanching and in vitro release rate foe betametahsone valerate creams. J Pharm Sci, 2006;81:104-6.
37. Torrado S, Torrado J, Cadórniga R. Topical application of albumin microspheres containing vitamin A: Drug release and availability. Int J Pharm, 1992;86:147-52.
38. Tursilli R, Piel G, Delattre L, Scalia S. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: Effect of the vehicle. Eur J Pharm Biopharm, 2007;66:483-7.
39. Varshosaz J, Keihanfar M. Development and evaluation of sustainedrelease propranolol wax microspheres. J Microencapsul, 2001;18:277-84.
40. Villalobos-Hernández JR, Müller-Goymann CC. Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media. Eur J Pharm Biopharm, 2005;60:113-22.
41. Villalobos-Hernández JR, Müller-Goymann CC. Physical stability, centrifugation tests, and entrapment efficiency studies of carnauba wax-decyl oleate nanoparticles used for the dispersion of inorganic sunscreens in aqueous media. Eur J Pharm Biopharm, 2006;63:115-27.
42. Villalobos-Hernández JR, Müller-Goymann CC. In vitro erythemal UV-A protection factors of inorganic sunscreens distributed in aqueous media using carnauba wax-decyl oleate nanoparticles. Eur J Pharm Biopharm, 2007;65:122-5.
43. Wang L, Ando S, Ishida Y, Ohtani H, Tsuge S, Nakayama T. Quantitative and discriminative analysis of carnauba waxes by reactive pyrolysis-GC in the presence of organic alkali using vertical microfurnance pyrolyzer. J Anal Appl Pyrolysis, 2001;58-59:525-37.
44. Wissing SA, Müller RH. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int J Pharm, 2002;242:373-5.
45. Xia Q, Saupe A, Müller RH, Souto EB. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci, 2008;29:473-82.
46. Yener G, Incegul T, Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxycinnamate. Int J Pharm, 2003;258:203-7.